MedTrace Logo

Evaluation of the Efficacy and Safety of PiQo4 for Facial Skin Rejuvenation

NCT03322475 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2019-03-07

No results posted yet for this study

Summary

A total of at least 20 healthy subjects at a single site, with at least two facial sub-areas with visible wrinkles with pigmentation and/or acne scars who wish to improve their skin appearance will be enrolled into the study. subjects will receive 3 treatments and return to follow-up visits at 1, 3, and 6 months following the last treatment.

Conditions

  • Skin Rejuvenation

Interventions

DEVICE

PiQo4 laser system

The PiQo4 laser system

Sponsors & Collaborators

  • Focus Medical, LLC

    lead INDUSTRY

Principal Investigators

  • Edward Ross, MD · Scripps Clinic Carmel Valley

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-03-12
Primary Completion
2019-07-30
Completion
2019-08-30
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03322475 on ClinicalTrials.gov